meglumine has been researched along with Hepatitis, Viral, Human in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esaulenko, EV; Isakov, VA; Kovalenko, AL; Radchenko, VG; Romantsov, MG; Shul'diakov, AA; Sologub, TV; Stel'makh, VV | 1 |
1 trial(s) available for meglumine and Hepatitis, Viral, Human
| Article | Year |
|---|---|
[Reamberin for pathogenetic therapy of acute and chronic viral diseases of the liver].
Topics: Acute Disease; Adolescent; Adult; Biomarkers; Chronic Disease; Cytoprotection; Female; Hepatitis, Viral, Human; Humans; Length of Stay; Male; Meglumine; Middle Aged; Succinates; Treatment Outcome; Young Adult | 2010 |